Cross-border policies

Health care without harm

Pharmaceuticals in the environment represent a global pollution problem – over 631 different pharmaceutical agents (or their metabolites) have been detected in at least 71 countries covering all continents. Pharmaceutical residues have been detected in surface water, sewage effluents, groundwater, drinking water, manure, soil, and other environmental matrices. Antibiotics in the environment can promote the

Health care without harm Read More »

Cross-border collaboration in public procurement

This report ‘How can voluntary cross-border collaboration in public procurement improve access to health technologies in Europe?’ examines the legal framework put in place by the EU to foster voluntary cross-border collaboration in the field of public procurement of health technologies. It looks at recent experiences and developments in cross-border collaboration across Europe and explores

Cross-border collaboration in public procurement Read More »

900 medical teams to connect across Europe for the benefit of patients

European Reference Networks (ERNs) are unique and innovative cross-border cooperation platforms between specialists for the diagnosis and treatment of rare or low prevalence complex diseases. In 2017 24 thematic ERNs, gathering over 900 highly specialised healthcare units from 26 countries, will begin working together on a wide range of issues, from bone disorders to haematological

900 medical teams to connect across Europe for the benefit of patients Read More »

Resistant bacteria spreading in hospitals across Europe

Antibiotic resistance is widespread across the whole of Europe. High resistance, often seen in the southern and eastern countries of the European Union, is also found in the eastern part of the European Region. In particular, resistant bacteria are spreading in hospitals and health care settings, putting patients at risk of contracting incurable diseases. This

Resistant bacteria spreading in hospitals across Europe Read More »

Improving access to medicines

A new WHO report provides insight into how countries in the WHO European Region can improve access and reduce medicine prices through strategic and well-planned procurement processes. It also addresses collaboration within and across countries to improve availability of affordable medicines for patients in the Region. Countries in the Region have varying capacity and negotiating

Improving access to medicines Read More »

Organ donation and transplant in the EU

Across Europe, 16 patients die every day waiting for the organs they need. However, there were over 800 more organ transplants in the EU in 2015, compared to 2014. This confirms an encouraging trend, with over 4000 additional transplants over 5 years, a 14{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96} increase compared with 2010. The ‘EU Action Plan on Organ Donation

Organ donation and transplant in the EU Read More »

Scroll to Top